enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. How Are ADHD & Anxiety in Adults Different? - AOL

   www.aol.com/adhd-anxiety-adults-different...

   Over-the-counter weight loss supplements are unlikely to be the magic pill for weight loss some claim to be. But there are other weight loss treatments with more scientific backing. Here are some ...

3. Management of attention deficit hyperactivity disorder

   en.wikipedia.org/wiki/Management_of_attention...

   Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...

4. Women turn to weight loss drugs in menopause: What to know ...

   www.aol.com/women-turn-weight-loss-drugs...

   As Mooney tried to navigate her body changes during menopause, when a woman's periods stop permanently, she said she turned to Ozempic, a medication used for weight loss that she credits with ...

5. Serotonin–norepinephrine reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Serotonin–norepinephrine...

   Off-label uses include treatments for attention-deficit hyperactivity disorder (ADHD), and obsessive–compulsive disorder (OCD). [1] SNRIs are monoamine reuptake inhibitors; specifically, they inhibit the reuptake of serotonin and norepinephrine. These neurotransmitters are thought to play an important role in mood regulation.

6. Lisdexamfetamine - Wikipedia

   en.wikipedia.org/wiki/Lisdexamfetamine

   Lisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used to treat attention deficit hyperactivity disorder (ADHD) in children and adults and for moderate-to-severe binge eating disorder in adults. [15]

7. Viloxazine - Wikipedia

   en.wikipedia.org/wiki/Viloxazine

   Viloxazine is indicated to treat attention deficit hyperactivity disorder (ADHD) in children age 6 to 12 years, adolescents age 13 to 17 years, and adults. [1]Analyses of clinical trial data suggest that viloxazine produces moderate reductions in symptoms; it is about as effective as atomoxetine and methylphenidate but with fewer side effects.